ArticlePCN reports : psychiatry and clinical neurosciences2025
Deliberate self-harm in adolescents with OTC-related psychiatric disorders: A study of prevalence and associated factors.
Article in PCN reports : psychiatry and clinical neurosciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Comment on "Deliberate self-harm in adolescents with OTC-related psychiatric disorders: A study of prevalence and associated factors".PCN reports : psychiatry and clinical neurosciences · 2026Article
- Deliberate self-harm in adolescents with OTC-related psychiatric disorders: A study of prevalence and associated factors.PCN reports : psychiatry and clinical neurosciences · 2025Article
Corrections and comments
- Commented on by
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: This study examines the issues of over-the-counter (OTC) drug abuse among adolescents from the perspective of deliberate self-harm and suicide. It aims to elucidate the clinical characteristics of psychiatric disorders related to OTC drug use and explore treatment approaches in the context of self-harm and suicide prevention. Methods: The study analyzed 93 adolescent cases (ages 10-19) of psychiatric disorders primarily attributed to OTC drug use, extracted from the "2024 Nationwide Survey on Drug-Related Psychiatric Disorders in Psychiatric Medical Facilities in Japan." Cases were categorized into two groups based on the presence or absence of incidents of deliberate self-harm within the past year. Clinical variables were compared between the two groups. Results: Incidents of deliberate self-harm within the past year were observed in 82.8% of the cases. Clinical features significantly associated with deliberate self-harm included being female, having an educational level of high school dropout or lower (including current enrollment in middle or high school), and engaging in sub-threshold drug use not meeting the diagnostic criteria for addiction. Furthermore, recent OTC drug use, severity of substance use disorder, and the presence of comorbid psychiatric disorders were not associated with "deliberate self-harm" among adolescents with OTC-related psychiatric disorders. The use of existing medical or non-medical resources designed for drug addiction treatment was also not associated with self-harming behavior. Conclusion: From the standpoint of suicide and self-harm prevention, conventional approaches centered on substance use disorder treatment and recovery support may not be sufficiently effective for this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.